Catherine Benedict1,2, Jody-Ann McLeggon1, Bridgette Thom3, Joanne F Kelvin3, Michelle Landwehr4, Samantha Watson4, Jennifer S Ford5. 1. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA. 2. Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA. 3. Memorial Sloan Kettering Cancer Center, New York, NY, USA. 4. The Samfund, Boston, MA, USA. 5. Hunter College and the Graduate Center, City University of New York, New York, NY, USA.
Abstract
OBJECTIVE: Young adult (YA) cancer survivors who received gonadotoxic therapy are at risk for impaired fertility and/or childbearing difficulties. This study explored the experiences and financial concerns of survivors pursuing family building through assisted reproductive technology (ART) and adoption. METHODS: Retrospective study of data collected from grant applications for financial assistance with family building. Grounded theory methodology using an inductive data-driven approach guided qualitative data analysis. RESULTS: Participants (N = 46) averaged 32 years old (SD = 3.4) were primarily female (81%) and married/partnered (83%). Four main themes were identified representing the (1) emotional experiences and (2) financial barriers to family building after cancer, (3) perceived impact on partners, and (4) disrupted life trajectory. Negative emotions were pervasive but were balanced with hope and optimism that parenthood would be achieved. Still, the combination of high ART/adoption costs, the financial impact of cancer, and limited sources for support caused extreme financial stress. Further, in the face of these high costs, many survivors reported worry and guilt about burdening partners, particularly as couples failed to meet personal and societal expectations for parenthood timelines. CONCLUSION: After cancer, YAs face numerous psychosocial and financial difficulties in their pursuits of family building when ART/adoption is needed to achieve parenthood. Survivors interested in future children may benefit from follow-up fertility counseling post-treatment including discussion of ART options, surrogacy, and adoption, as appropriate, and potential barriers. Planning for the financial cost and burden in particular may help to avoid or mitigate financial stress later on.
OBJECTIVE: Young adult (YA) cancer survivors who received gonadotoxic therapy are at risk for impaired fertility and/or childbearing difficulties. This study explored the experiences and financial concerns of survivors pursuing family building through assisted reproductive technology (ART) and adoption. METHODS: Retrospective study of data collected from grant applications for financial assistance with family building. Grounded theory methodology using an inductive data-driven approach guided qualitative data analysis. RESULTS: Participants (N = 46) averaged 32 years old (SD = 3.4) were primarily female (81%) and married/partnered (83%). Four main themes were identified representing the (1) emotional experiences and (2) financial barriers to family building after cancer, (3) perceived impact on partners, and (4) disrupted life trajectory. Negative emotions were pervasive but were balanced with hope and optimism that parenthood would be achieved. Still, the combination of high ART/adoption costs, the financial impact of cancer, and limited sources for support caused extreme financial stress. Further, in the face of these high costs, many survivors reported worry and guilt about burdening partners, particularly as couples failed to meet personal and societal expectations for parenthood timelines. CONCLUSION: After cancer, YAs face numerous psychosocial and financial difficulties in their pursuits of family building when ART/adoption is needed to achieve parenthood. Survivors interested in future children may benefit from follow-up fertility counseling post-treatment including discussion of ART options, surrogacy, and adoption, as appropriate, and potential barriers. Planning for the financial cost and burden in particular may help to avoid or mitigate financial stress later on.
Authors: Jessica R Gorman; Brian W Whitcomb; Daniel Standridge; Vanessa L Malcarne; Sally A D Romero; Samantha A Roberts; H Irene Su Journal: J Cancer Surviv Date: 2016-09-30 Impact factor: 4.442
Authors: Jennifer E Mersereau; Linnea R Goodman; Allison M Deal; Jessica R Gorman; Brian W Whitcomb; H Irene Su Journal: Cancer Date: 2013-08-26 Impact factor: 6.860
Authors: Michelle S Landwehr; Samantha E Watson; Catherine F Macpherson; Katherine A Novak; Rebecca H Johnson Journal: Cancer Med Date: 2016-02-07 Impact factor: 4.452
Authors: Taylor L Morgan; Braedon P Young; Keagan G Lipak; Vicky Lehmann; James Klosky; Gwendolyn P Quinn; Cynthia A Gerhardt; Leena Nahata Journal: J Adolesc Young Adult Oncol Date: 2020-04-22 Impact factor: 2.223
Authors: Clare Meernik; Jennifer E Mersereau; Christopher D Baggett; Stephanie M Engel; Lisa M Moy; Nancy T Cannizzaro; Mary Peavey; Lawrence H Kushi; Chun R Chao; Hazel B Nichols Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-05-04 Impact factor: 4.090
Authors: Catherine Benedict; Katherine L Dauber-Decker; Jennifer S Ford; D'Arcy King; David Spiegel; Lidia Schapira; Pamela Simon; Michael Diefenbach Journal: JMIR Cancer Date: 2022-05-31
Authors: Alexandra C Himelhoch; Taylor M Datillo; Marrit A Tuinman; Cynthia A Gerhardt; Vicky Lehmann Journal: J Adolesc Young Adult Oncol Date: 2021-05-17 Impact factor: 2.223
Authors: Catherine Benedict; Katherine L Dauber-Decker; D'Arcy King; Alexandria Hahn; Jennifer S Ford; Michael Diefenbach Journal: JMIR Form Res Date: 2021-01-22
Authors: Catherine Benedict; Jen-Ling Nieh; Alexandria L Hahn; Alyssa McCready; Michael Diefenbach; Jennifer S Ford Journal: Support Care Cancer Date: 2020-09-05 Impact factor: 3.359
Authors: Catherine Benedict; Jennifer S Ford; Lidia Schapira; Pamela Simon; David Spiegel; Michael Diefenbach Journal: BMJ Open Date: 2019-12-29 Impact factor: 3.006